Third time lucky for Parkinson's drugs?
Newly-formed Brane Discovery has licensed a Parkinson's research programme to become the third company in three years to own the potentially first-in-class drug candidates.
Archives for June 4, 2007
Danish biopharma to supply 20 million smallpox vaccines to US
Denmark-based Bavarian Nordic has clocked up a whopping $500m (€371m) contract with the US government to supply millions of doses of smallpox vaccine.
Ipsen boosts manufacturing in France
European pharma group Ipsen is planning to shell out a hefty sum to upgrade its facilities in Dreux, France and bolster activities in strategic areas.
Specialist label maker opts for Datalase technique
Schreiner MediPharm, a leading manufacturer of 'intelligent' labels has chosen Datalase's flagship Packmark printing technique for its customers in the pharma industry.
AstraZeneca picks up abandoned DSM facility
Just weeks after announcing intentions to snap up biologics firm MedImmune, AstraZeneca has acquired DSM's old biologics manufacturing facility in Montreal, Canada, a site that's been gathering dust since it was mothballed by the firm last year.
Bio-film uses fuel and dairy byproducts
A new method to create biodegradable protective films from dairy and biofuel byproducts has been developed, US scientists announced today.
SPI Pharma responds to Roquette's patent claim
SPI Pharma has denied infringing Roquette Freres mannitol excipient patent and has claimed instead that Roquette's patent is invalid.
Thermo launches new proteomics MS
Thermo Fisher Scientific has introduced a range of powerful new mass spectroscopy products at the 55th ASMS Conference on Mass Spectrometry currently being held in Indianapolis, US.
deltaDOT lets fly with new drug discovery tool
DeltaDOT has been given a government grant to commercially develop a new tool to allow researchers to reduce dramatically the time it takes to weed out unsuitable drug candidates.
UK to pioneer carbon footprint labelling innovation
In a bid to push manufacturers to reduce their greenhouse gas emissions, the UK government last week unveiled a proposal that could pave the way for "carbon footprint" labels on products.
Lucrative prospects for India-UK pharma trade
The pharmaceutical and healthcare industries will help to push trade between India and the United Kingdom up by 60 per cent within three years, claims a soon-to-be released report.
Amgen bolsters portfolio in kidney disease via $420m buy
Amgen will strengthen its drug portfolio aimed at fighting renal disease after agreeing to acquire Ilypsa, a private biotechnology company which is developing a novel drug for the treatment of elevated blood phosphate (hyperphosphataemia) in chronic...
Revolutionary Phase I trial design speeds up development
A new approach to Phase I clinical trials could revolutionise drug development, enabling innovative drugs to get to market faster and cheaper.